IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
Hospira Holdings (SA) Pty Ltd
Hospira Holdings is a Proprietary Company that generates the majority of its income from the Pharmaceutical Product Manufacturing industry. In 2024 the company generated total revenue of $215,848,000 including sales and other revenue. In 2024 Hospira Holdings had 430 employees including employees from all subsidiaries under the company's control. The Chief Executive of Hospira Holdings is Unknown Bradley James Apps whose official title is CHIEF EXECUTIVE OFFICER. The Chairman of Hospira Holdings is Mr Simon Cameron whose official title is Director. Hospira Holdings (SA) Pty Ltd is the holding company for a group of businesses that develop, manufacture and distribute injectable pharmaceuticals, medication management products, protein, and peptide therapeutics. The company's products include: Medicines: The company has a range of proprietary medicines for the treatment of central nervous disorders. Specialty Injectable Pharmaceuticals: Includes intravenous medicines and IV safety systems. The safety systems include the LifeShield and Clave brands. Biosimilars: Specialty medicines produced in living systems to treat complex diseases such as breast cancer and autoimmune disorders. Clinical Software: Software providing process and risk analysis for clinics. Infusion Pumps: Includes products for medication delivery and pain management under the Plum, Lifecare, and Sapphire brands. IV Sets: IV safety devices to control and prevent infection, needlestick injuries, and IV medicine delivery.
Access this data your way
The Hospira Holdings (SA) Pty Ltd Industry analysis is available in multiple formats to fit seamlessly into your workflow.
API Data Delivery
Feed trusted, human-driven industry intelligence straight into your platform.
Integrations
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
What's included in this industry analysis
IBISWorld's research coverage on the Hospira Holdings (SA) Pty Ltd includes market sizing, forecasting, data and analysis. The most recent publication will be as current as of March 2026.
Company Details
What’s this enterprise profile about?
Hospira Holdings (SA) Pty Ltd, trading as Hospira Holdings, operates under the ABN 14 121 147 019 and was incorporated on 09 August 2006. Hospira Holdings (SA) Pty Ltd primarily operates in the Pharmaceutical Product Manufacturing industry in Australia.
Key Personnel
What’s included in the Key Personnel chapter?
The Key Personnel chapter outlines the principal leadership positions within Hospira Holdings (SA) Pty Ltd, including the Chairman, Board members, Chief Executive Officer, and other key management personnel. It provides an overview of the company’s governance and executive structure, along with a breakdown of gender diversity across leadership roles, offering insight into the composition of the organisation’s senior team.
Financials
What’s included in the Financials chapter?
The Financials chapter presents Hospira Holdings (SA) Pty Ltd’s historical financial performance, including detailed profit and loss statements outlining sales revenue, cost of sales, and profitability. It also incorporates balance sheet data, providing a breakdown of assets and liabilities, as well as additional financial metrics such as the number of shares on issue. Together, these disclosures offer a comprehensive view of the company’s financial position and performance over time.
Growth & Ratios
What’s included in the Growth & Rations chapter?
The Growth & Ratios chapter provides historical data on key financial performance indicators, enabling an assessment of the company’s operational efficiency, profitability, and financial structure over time. Metrics covered include return on equity, return on assets, profit margins, revenue per employee, as well as gearing and leverage ratios, offering a comprehensive view of performance trends and capital management.
Operating Segments
What’s included in the Operating Segments chapter?
The Operating Segments chapter provides an overview of the revenue composition and asset allocation across the various industries in which Hospira Holdings (SA) Pty Ltd operates. It offers insights into how the company’s financial performance is distributed among its core business segments, highlighting the relative contribution of each industry to total revenue.
Competitor Benchmarking
What’s included in the Competitor Benchmarking chapter?
The Competitor Benchmarking chapter includes a comparative assessment of Hospira Holdings (SA) Pty Ltd’s key financial, growth, and valuation ratios against industry averages to evaluate its competitive position. It analyses valuation metrics such as price-to-earnings, price-to-book, enterprise value to EBITDA, and enterprise value to sales, alongside core financial indicators including liquidity ratios and profitability measures.
Shareholders
What’s included in the Shareholders chapter?
The Shareholders chapter provides a breakdown of the ownership structure of Hospira Holdings (SA) Pty Ltd, identifying key shareholders and outlining their respective ownership interests. This section offers insight into the concentration of shareholdings, the presence of institutional or strategic investors, and the overall distribution of equity within the company.
Subsidiaries
What’s included in the Subsidiaries chapter?
The Subsidiaries chapter provides an overview of the companies and business entities that are wholly or partially owned by Hospira Holdings (SA) Pty Ltd. It outlines the ownership structure of each subsidiary, offering insight into the broader corporate group and how these entities contribute to the company’s overall activities and performance.
History
What’s included in the History chapter?
The History chapter presents a overview of Hospira Holdings (SA) Pty Ltd’s development, highlighting key milestones and significant corporate events since its incorporation. It includes the company’s incorporation date and outlines major strategic, operational, and structural developments, providing context for its evolution and current market position.
Trusted by industry professionals
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
Frequently Asked Questions
What is Hospira Holdings (SA) Pty Ltd?
Hospira Holdings (SA) Pty Ltd is the holding company for a group of businesses that develop, manufacture and distribute injectable pharmaceuticals, medication management products, protein, and peptide therapeutics. The company's products include: Medicines: The company has a range of proprietary medicines for the treatment of central nervous disorders. Specialty Injectable Pharmaceuticals: Includes intravenous medicines and IV safety systems. The safety systems include the LifeShield and Clave brands. Biosimilars: Specialty medicines produced in living systems to treat complex diseases such as breast cancer and autoimmune disorders. Clinical Software: Software providing process and risk analysis for clinics. Infusion Pumps: Includes products for medication delivery and pain management under the Plum, Lifecare, and Sapphire brands. IV Sets: IV safety devices to control and prevent infection, needlestick injuries, and IV medicine delivery.
What industry does Hospira Holdings (SA) Pty Ltd operate in?
Hospira Holdings (SA) Pty Ltd, trading as Hospira Holdings, is a Private Company that generates the majority of its income from the Pharmaceutical Product Manufacturing industry in Australia.
Where is Hospira Holdings (SA) Pty Ltd located?
Murray Cod Australia Limited company is based at 151 Clarence Street, Sydney, New South Wales, Australia.
Who is the CEO of Hospira Holdings (SA) Pty Ltd?
The DIRECTOR of Hospira Holdings (SA) Pty Ltd is Bradley James Apps and the DIRECTOR is Lauren Adler.
What was Hospira Holdings (SA) Pty Ltd’s revenue in 2025?
In 2025, Hospira Holdings (SA) Pty Ltd generated total revenue of approximately $215.8 million.
Cut through the noise with intelligence you can trust
